| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390400A2 Pharmaceutical use for secreted bacterial effector proteins |
| 02/25/2004 | EP1390399A2 Long lasting fusion peptide inhibitors for hiv infection |
| 02/25/2004 | EP1390393A2 Pentapeptide compounds and uses related thereto |
| 02/25/2004 | EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions |
| 02/25/2004 | EP1390383A1 Antisense permeation enhancers |
| 02/25/2004 | EP1390370A1 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| 02/25/2004 | EP1390345A1 Polythiourea lipid derivatives |
| 02/25/2004 | EP1390138A1 Vegetable protein-based microcapsules |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
| 02/25/2004 | EP1390073A2 Compositions having enhanced pharmacokinetic characteristics |
| 02/25/2004 | EP1390070A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 02/25/2004 | EP1390063A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 02/25/2004 | EP1390053A2 Hcg formulation |
| 02/25/2004 | EP1390048A2 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders |
| 02/25/2004 | EP1390047A1 Taste masking pharmaceutical composition |
| 02/25/2004 | EP1390044A1 Injectable pamidronate disodium |
| 02/25/2004 | EP1390031A2 Topical composition containing a fungicide |
| 02/25/2004 | EP1390024A1 Isostearic acid salts as permeation enhancers |
| 02/25/2004 | EP1390023A2 Pharmaceutical salts |
| 02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 02/25/2004 | EP1390019A1 Controlled release drug delivery device |
| 02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
| 02/25/2004 | EP1390015A1 Taste-masking of highly water-soluble drugs |
| 02/25/2004 | EP1390014A1 Composition and methods for treatment of hyperplasia |
| 02/25/2004 | EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions |
| 02/25/2004 | EP1390012A1 Novel methods and compositions for delivering macromolecules to or via the respiratory tract |
| 02/25/2004 | EP1390011A2 Control of compactability through crystallization |
| 02/25/2004 | EP1292293B1 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same |
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP1230223B1 Oligobenzimidazole derivatives and their use as dna transfection agents |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1202739A4 Rapid immediate release oral dosage form |
| 02/25/2004 | EP1175203A4 Folic acid supplement |
| 02/25/2004 | EP1138333B1 Medicinal compositions for oral use |
| 02/25/2004 | EP1135481B1 New oligomeric conjugates liable to transfer biological molecules into cells |
| 02/25/2004 | EP1039908B1 Molecular dispersion composition with enhanced bioavailability |
| 02/25/2004 | EP1037609B1 Aqueous insecticidal pour-on formulation |
| 02/25/2004 | EP1037607B1 Novel suppository form comprising an acid-labile active compound |
| 02/25/2004 | EP0988797B1 Use of compositions for postgastrectomic mineral supply |
| 02/25/2004 | EP0954336B1 Membrane incorporation of texaphyrins |
| 02/25/2004 | EP0825853B1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids |
| 02/25/2004 | CN1477977A Compositions of N-(methy/ethy/aminocarbony/)-4-(3-methy/pheny/amino)-3-pyridy/sulfonamide and cyclic oligosaccharides |
| 02/25/2004 | CN1477973A Split enveloped virus preparation |
| 02/25/2004 | CN1477972A Method for botaining antigenic aggregates and use thereof in formulations |
| 02/25/2004 | CN1477966A Shark meat extract |
| 02/25/2004 | CN1477965A Pharmaceutical product for treatment and diagnosis of tumors and method for preparation of liqid free fraction of blood plasma |
| 02/25/2004 | CN1477955A Parenteral dosage forms comprising suspension of tramadol salt and diclofenac salt |
| 02/25/2004 | CN1477954A 可消耗容器 Consumable containers |
| 02/25/2004 | CN1477953A Process for preparing pharmaceutical compositions for use with soft gelatin formulations |
| 02/25/2004 | CN1477952A Compositions for sustained delivery of hydrophobic drugs and process for preparation thereof |
| 02/25/2004 | CN1476898A Compound skeleton tablet capable of prolonging release after oral administrationi for curing common cold |
| 02/25/2004 | CN1476897A Preparation technique of protein medicine microsphere carrier with small grain size |
| 02/25/2004 | CN1476896A Production method of nano medicine carrier |
| 02/25/2004 | CN1476840A Preparation method of stable fleabane extract injection |
| 02/25/2004 | CN1476831A Biphenyl double-ester solid slowly-releasing composite |
| 02/25/2004 | CN1476828A Suspended preparation of biguanide vanadium complex-medicine for curing diabetes and its application |
| 02/25/2004 | CN1476826A Oral disintegrant tablet and its preparation method |
| 02/25/2004 | CN1476825A Grain prolamin microsphere and preparation method |
| 02/25/2004 | CN1476824A Co-ground material of Chinese medicine extract with poor water-solubility and water soluble high molecule and its preparation method |
| 02/25/2004 | CN1476823A Co-ground material of Chinese medicine decocting piece and water-soluble high-molecule and its preparation method |
| 02/25/2004 | CN1139657C Coated microgranules for stabilizing lactic acid bacteria |
| 02/25/2004 | CN1139629C Diluting and disintegrating composition , preparing method and use thereof |
| 02/25/2004 | CN1139403C Ophthalmic composition comprising beta-blocker |
| 02/25/2004 | CN1139402C Usage of benzoisothiazole ketone compound being used as percutaneous medicine-feeding osmotic promoting agent and preparation process thereof |
| 02/25/2004 | CN1139386C Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
| 02/25/2004 | CN1139385C Method and composition for lipidization of hydrophilic molecules |
| 02/25/2004 | CN1139380C Water based externally used cream containing nitroglycerin, and prepn method and use thereof |
| 02/25/2004 | CN1139378C Oral preparation containing at least one active pharmaceutical compound in matrix capable of swelling in aqueous medium |
| 02/25/2004 | CN1139377C Granulates comprising water soluble compound and cellulose |
| 02/24/2004 | USRE38443 Stabilized aspirin compositions and method of preparation of oral and topical use |
| 02/24/2004 | US6696517 Use of copolymers based on acrylamidoalkylsulfonic acids as thickeners in preparations comprising organic solvents |
| 02/24/2004 | US6696500 Bioactive substance having acidic group and a biodegradable polymer having an optionally protected basic group, such as a polylactone that has been esterified, amidated, or thioesterified with a compound having cyclic amino groups |
| 02/24/2004 | US6696493 Treating chronic uremic patients undergoing periodic dialysis |
| 02/24/2004 | US6696482 Formulations for hydrophobic pharmaceutical agents |
| 02/24/2004 | US6696426 Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems |
| 02/24/2004 | US6696276 Vasopermeability-enhancing conjugates |
| 02/24/2004 | US6696094 Herbal pharmaceutical composition for treatment of HIV/AIDS patients |
| 02/24/2004 | US6696091 Pharmaceutical composition of topiramate |
| 02/24/2004 | US6696090 Micronized medical powder electrostatically charged by corona, induction, or triboelectricity; lung airway or oral inhalation administration of antiasthmatic agent |
| 02/24/2004 | US6696089 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 02/24/2004 | US6696088 Useful for decreasing the potential for abuse of the opioid agonist contained therein; for use in therapy of pain |
| 02/24/2004 | US6696085 Methacrylic acid copolymer |
| 02/24/2004 | US6696082 Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier |
| 02/24/2004 | US6696081 Lipids where the glycerol backbone is replaced with a carbohydrate; conjugates; drug delivery |
| 02/24/2004 | US6696080 Vortexing lipid film with water; homogenizing suspension; repeatedly freeze-thawing in liquid nitrogen; encapsulation; giant multivesicular liposomes |
| 02/24/2004 | US6696072 Mixture of phentolamine mesylate, papaverine hydrochloride, and alprostadil in buffer containing l-arginine and glycine injected into penis |
| 02/24/2004 | US6696060 Methods for sterilizing preparations of monoclonal immunoglobulins |
| 02/24/2004 | US6696056 Pharmaceutical compositions of erythropoietin |
| 02/24/2004 | US6696055 Disinfectant substance comprising an iodine impregnated resin for use in sterilizing a fluid such as water or air |
| 02/24/2004 | US6696038 Cationic lipopolymer as biocompatible gene delivery agent |
| 02/24/2004 | CA2352802C Preparation of multiwall polymeric microcapsules from hydrophilic polymers |
| 02/24/2004 | CA2315067C Aqueous insecticidal pour-on formulation |
| 02/24/2004 | CA2305750C Stable solution of zinc and bicarbonate ions |
| 02/24/2004 | CA2125401C Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
| 02/24/2004 | CA2078860C Film-forming product intended for coating solid forms |
| 02/19/2004 | WO2004014973A2 Biodegradable polymer |
| 02/19/2004 | WO2004014951A2 Binding molecules |
| 02/19/2004 | WO2004014929A1 Derivatives of monosaccharides for drug discovery |